Univariate analyses of survival using Q-RT/PCR expression of 20 genes
Gene* . | N . | Median survival, y (95% CI) . | P . |
|---|---|---|---|
| AZU1 | .024 | ||
| Less than 0.056 | 16 | 3.5 (2.5-4.5) | |
| More than 0.055 | 52 | 9.4 (7.5-11.3) | |
| CD7 | .028 | ||
| Less than 0.73 | 34 | 9.8 (8.4-11.3) | |
| More than 0.72 | 34 | 7.8 (4.1-11.6) | |
| CEBPA | .56 | ||
| Less than 0.074 | 34 | 12.8 (5.2-20.4) | |
| More than 0.073 | 34 | 9.2 (7.1-11.3) | |
| CG | .51 | ||
| Less than 0.098 | 32 | 9.8 (2.3-17.4) | |
| More than 0.097 | 32 | 9.2 (7.3-11.1) | |
| CLC | .82 | ||
| Less than 2.22 | 32 | 9.8 (2.3-17.4) | |
| More than 2.21 | 32 | 8.2 (5.99-10.4) | |
| CXCR4 | .19 | ||
| Less than 1.15 | 34 | 8.7 (2.9-14.5) | |
| More than 1.14 | 34 | 9.4 (6.8-12.0) | |
| DF | .13 | ||
| Less than 0.073 | 34 | 5.1 (0-11.8) | |
| More than 0.072 | 34 | 9.4 (7.2-11.5) | |
| ECP | .14 | ||
| Less than 0.067 | 32 | 8.7 (1-16.4) | |
| More than 0.066 | 32 | 9.4 (6.7-12.0) | |
| EDN | .15 | ||
| Less than 0.035 | 32 | 8.7 (3.0-14.4) | |
| More than 0.034 | 32 | 9.4 (6.8-11.9) | |
| ELA2 | .021 | ||
| Less than 0.32 | 50 | 8.7 (4.1-13.3) | |
| More than 0.31 | 16 | 12.1 (8.9-14.1) | |
| FUT4 | .82 | ||
| Less than 3.34 | 32 | 9.2 (4.3-14.1) | |
| More than 3.33 | 32 | 8.2 (5.8-10.5) | |
| GFI1 | .52 | ||
| Less than 0.029 | 32 | 9.2 (4.3-14.1) | |
| More than 0.028 | 32 | 8.2 (3.2-13.3) | |
| HIST1H2BG | .89 | ||
| Less than 0.56 | 32 | 8.7 (7.1-10.3) | |
| More than 0.55 | 32 | 3.6 (2.3-16.4) | |
| HM74 | .45 | ||
| Less than 0.071 | 32 | 9.8 (0-20.9) | |
| More than 0.070 | 32 | 9.2 (7.6-10.8) | |
| HTM4 | .26 | ||
| Less than 0.019 | 32 | 8.7 (3.6-13.8) | |
| More than 0.018 | 32 | 9.2 (7.4-11.0) | |
| MBP | .016 | ||
| Less than 0.045 | 16 | 3.5 (0-7.0) | |
| More than 0.044 | 48 | 9.4 (7.2-11.5) | |
| MPO | .42 | ||
| Less than 0.021 | 34 | 9.8 (2-17.7) | |
| More than 0.020 | 34 | 9.2 (7.2-11.5) | |
| PR-3 | .027 | ||
| Less than 0.011 | 34 | 5.1 (0.9-9.2) | |
| More than 0.010 | 34 | 12.1 (7.2-16.9) | |
| SMA4 | .047 | ||
| Less than 1.65 | 32 | 9.2 (4.5-13.8) | |
| More than 1.64 | 32 | 9.4 (2.3-16.4) | |
| STARD1 | < .001 | ||
| Less than 0.027 | 32 | 5.1 (4.4-5.7) | |
| More than 0.026 | 32 | 12.1 (7.1-17.0) |
Gene* . | N . | Median survival, y (95% CI) . | P . |
|---|---|---|---|
| AZU1 | .024 | ||
| Less than 0.056 | 16 | 3.5 (2.5-4.5) | |
| More than 0.055 | 52 | 9.4 (7.5-11.3) | |
| CD7 | .028 | ||
| Less than 0.73 | 34 | 9.8 (8.4-11.3) | |
| More than 0.72 | 34 | 7.8 (4.1-11.6) | |
| CEBPA | .56 | ||
| Less than 0.074 | 34 | 12.8 (5.2-20.4) | |
| More than 0.073 | 34 | 9.2 (7.1-11.3) | |
| CG | .51 | ||
| Less than 0.098 | 32 | 9.8 (2.3-17.4) | |
| More than 0.097 | 32 | 9.2 (7.3-11.1) | |
| CLC | .82 | ||
| Less than 2.22 | 32 | 9.8 (2.3-17.4) | |
| More than 2.21 | 32 | 8.2 (5.99-10.4) | |
| CXCR4 | .19 | ||
| Less than 1.15 | 34 | 8.7 (2.9-14.5) | |
| More than 1.14 | 34 | 9.4 (6.8-12.0) | |
| DF | .13 | ||
| Less than 0.073 | 34 | 5.1 (0-11.8) | |
| More than 0.072 | 34 | 9.4 (7.2-11.5) | |
| ECP | .14 | ||
| Less than 0.067 | 32 | 8.7 (1-16.4) | |
| More than 0.066 | 32 | 9.4 (6.7-12.0) | |
| EDN | .15 | ||
| Less than 0.035 | 32 | 8.7 (3.0-14.4) | |
| More than 0.034 | 32 | 9.4 (6.8-11.9) | |
| ELA2 | .021 | ||
| Less than 0.32 | 50 | 8.7 (4.1-13.3) | |
| More than 0.31 | 16 | 12.1 (8.9-14.1) | |
| FUT4 | .82 | ||
| Less than 3.34 | 32 | 9.2 (4.3-14.1) | |
| More than 3.33 | 32 | 8.2 (5.8-10.5) | |
| GFI1 | .52 | ||
| Less than 0.029 | 32 | 9.2 (4.3-14.1) | |
| More than 0.028 | 32 | 8.2 (3.2-13.3) | |
| HIST1H2BG | .89 | ||
| Less than 0.56 | 32 | 8.7 (7.1-10.3) | |
| More than 0.55 | 32 | 3.6 (2.3-16.4) | |
| HM74 | .45 | ||
| Less than 0.071 | 32 | 9.8 (0-20.9) | |
| More than 0.070 | 32 | 9.2 (7.6-10.8) | |
| HTM4 | .26 | ||
| Less than 0.019 | 32 | 8.7 (3.6-13.8) | |
| More than 0.018 | 32 | 9.2 (7.4-11.0) | |
| MBP | .016 | ||
| Less than 0.045 | 16 | 3.5 (0-7.0) | |
| More than 0.044 | 48 | 9.4 (7.2-11.5) | |
| MPO | .42 | ||
| Less than 0.021 | 34 | 9.8 (2-17.7) | |
| More than 0.020 | 34 | 9.2 (7.2-11.5) | |
| PR-3 | .027 | ||
| Less than 0.011 | 34 | 5.1 (0.9-9.2) | |
| More than 0.010 | 34 | 12.1 (7.2-16.9) | |
| SMA4 | .047 | ||
| Less than 1.65 | 32 | 9.2 (4.5-13.8) | |
| More than 1.64 | 32 | 9.4 (2.3-16.4) | |
| STARD1 | < .001 | ||
| Less than 0.027 | 32 | 5.1 (4.4-5.7) | |
| More than 0.026 | 32 | 12.1 (7.1-17.0) |
Expression values by Q-RT/PCR are given as a ratio of amplification of the individual gene and the ABL control gene